Stigmasterol attenuates atherosclerosis by inhibiting inflammatory signaling and foam cell formation.

Lu B, Xiao F, Zhang Q, Xie Y, Wang M, Simal-Gandara J, Liu Y, Efferth T, Huang W, Shen J, Xiao J

Open source

DOI
10.1002/imo2.70056
Published
2025 Dec
Container
iMetaOmics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/imo2.70056,
  title = {Stigmasterol attenuates atherosclerosis by inhibiting inflammatory signaling and foam cell formation.},
  author = {Lu B and Xiao F and Zhang Q and Xie Y and Wang M and Simal-Gandara J and Liu Y and Efferth T and Huang W and Shen J and Xiao J},
  year = {2025},
  journal = {iMetaOmics},
  doi = {10.1002/imo2.70056},
  url = {https://doi.org/10.1002/imo2.70056}
}

RIS

TY  - JOUR
TI  - Stigmasterol attenuates atherosclerosis by inhibiting inflammatory signaling and foam cell formation.
AU  - Lu B
AU  - Xiao F
AU  - Zhang Q
AU  - Xie Y
AU  - Wang M
AU  - Simal-Gandara J
AU  - Liu Y
AU  - Efferth T
AU  - Huang W
AU  - Shen J
AU  - Xiao J
PY  - 2025
JO  - iMetaOmics
DO  - 10.1002/imo2.70056
UR  - https://doi.org/10.1002/imo2.70056
ER  - 

APA

B, L., F, X., Q, Z., Y, X., M, W., J, S., Y, L., T, E., W, H., J, S., & J, X. (2025). Stigmasterol attenuates atherosclerosis by inhibiting inflammatory signaling and foam cell formation.. iMetaOmics. https://doi.org/10.1002/imo2.70056

Source records